Osaka, Japan

Masatoshi Arimura



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Masatoshi Arimura: Innovator in Pharmaceutical Preparations

Introduction

Masatoshi Arimura is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the stability and purity of pharmaceutical preparations.

Latest Patents

Masatoshi Arimura holds a patent for a mirabegron-containing tablet, which includes a method for producing a mirabegron-containing pharmaceutical preparation and a method for producing a mirabegron-containing granulated product. The invention aims to provide a mirabegron-containing tablet that maintains the amorphous form of mirabegron even after long-term storage. Additionally, it seeks to ensure that the purity of mirabegron is preserved while preventing the generation of related substances during storage. The pharmaceutical preparation includes mirabegron, hypromellose, and polyvinylpyrrolidone, and may also contain a spray-dried granulated product.

Career Highlights

Masatoshi Arimura is associated with Sawai Pharmaceutical Co., Ltd., where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has been instrumental in advancing the company's product offerings.

Collaborations

He has collaborated with notable colleagues, including Toshihiro Yanagi and Kenji Nozawa, to further enhance the quality and effectiveness of pharmaceutical products.

Conclusion

Masatoshi Arimura's innovative work in pharmaceutical preparations exemplifies the importance of research and development in the healthcare industry. His contributions continue to impact the field positively, ensuring better drug formulations for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…